Word

HILLTHRU

Status

Pending

Status Code

730

Status Date

Monday, August 19, 2024

Serial Number

97898042

Mark Type

4

Filing Date

Thursday, April 20, 2023

Published for Opposition

Tuesday, January 30, 2024

Trademark Owner History

Eli Lilly and Company - Owner At Publication

Classifications

5 Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases

Trademark Events

Apr 24, 2023

New Application Entered

Dec 15, 2023

Assigned To Examiner

Apr 28, 2023

New Application Office Supplied Data Entered

Dec 27, 2023

Approved For Pub - Principal Register

Jan 30, 2024

Official Gazette Publication Confirmation E-Mailed

Jan 10, 2024

Notification Of Notice Of Publication E-Mailed

Jan 30, 2024

Published For Opposition

Mar 26, 2024

Noa E-Mailed - Sou Required From Applicant

Aug 19, 2024

Sou Teas Extension Received

Aug 19, 2024

Notice Of Approval Of Extension Request E-Mailed

Aug 19, 2024

Sou Extension 1 Granted

Aug 19, 2024

Sou Extension 1 Filed